CPC C12N 5/0697 (2013.01) [C12N 5/0619 (2013.01); C12N 5/0658 (2013.01); G01N 33/5082 (2013.01); C12N 2500/38 (2013.01); C12N 2501/01 (2013.01); C12N 2501/105 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/13 (2013.01); C12N 2501/15 (2013.01); C12N 2501/41 (2013.01); C12N 2501/734 (2013.01); C12N 2501/999 (2013.01); C12N 2502/081 (2013.01); C12N 2502/1335 (2013.01); C12N 2506/45 (2013.01); C12N 2513/00 (2013.01)] | 17 Claims |
1. A method for producing functionally integrated human cortico-spinal-muscle assembled spheroids in vitro, the method comprising:
(i) inducing in a human pluripotent stem cell suspension culture a neural fate to provide a first spheroid of neural progenitor cells and a second spheroid of neural progenitor cells;
(ii) differentiating the neural progenitor cells in the first spheroid to differentiate into human spinal cord spheroids (hSC), and culturing the hSC with human skeletal muscle cells (hSkM) under integrating conditions to generate hSC-hSkM spheroids;
(iii) differentiating the neural progenitor cells in the second spheroid to differentiate into human cortical spheroids (hCS);
(iv) culturing the hCS and hSC-hSkM under conditions permissive for spheroid fusion while maintaining for an extended period of time in neural medium; wherein a functionally integrated human cortico-spinal-muscle assembled spheroid is differentiated comprising interacting glutamatergic projection neurons, motor neurons, interneurons, and muscle cells.
|